Transparent Methods

Cell culture and cardiac directed differentiation.
Human embryonic stem cells (RUES2) were maintained and cardiac directed differentiation was performed based on methods previously described (Palpant et al., 2015a) . Briefly, hESCs were seeded on Matrigel (BD) coated plates and directed differentiation was performed using a combination of activin A and BMP4 and small molecule activation and inhibition of the WNT/β-catenin signaling pathway as illustrated in Figure 1D . Endothelial differentiation was performed as previously described (Palpant et al., 2015b) . Briefly, differentiation was initiated with Activin A (100 ng/mL for endocardial-like endothelium (EECs) and 50 ng/mL for hemogenic endothelium (HECs)) in RPMI B27 without insulin and 1x matrigel. On day 1, media was changed to BMP4 (5 ng/mL for EECs and 40 ng/mL for HECs) in RPMI B27 minus insulin with 1 µM CHIR-99021. On day 2 media was changed to Stempro34 (Invitrogen, 10640019) backbone media containing 200 ng/mL VEGF (Peprotech, , 5 ng/mL bFGF (Peprotech, 100-18B), 10 ng/mL BMP4 (R&D SYSTEMS, 314-BP-050), 4x10-4 M monothioglycerol, 50 μg/mL Ascorbic Acid, 2mM L-Glutamine (Invitrogen, 25030-081) , and pen-strep (Invitrogen, 15140-163) and remained until day 5 when cells were phenotyped.
Zebrafish strains and husbandry.
Wild-type (AB; zebrafish International Resource Center, Eugene, OR, USA), tcf21:DsRed2 (Kikuchi et al., 2011) , cmlc2:DsRed-nuc (Mably et al., 2003) , myl7:GFP (Burns et al., 2005) and hsWNT8:GFP (Weidinger et al., 2005) were used and maintained using standard procedures (Westerfield, 2000) in accordance with the Institutional Animal Care and Use Committee-approved protocols.
Flow Cytometry.
Cardiomyocyte purity and immaturity was assessed by flow cytometry using cardiac troponin T (Thermo Scientific, 1:100) antibody and smooth muscle actin (SMA; Abcam, 1:200) or the isotype control on day 14 of hESC directed differentiation. Human ESC derived endothelial cells were analyzed on day 5 with antibodies against human VEGF R2/KDR PE (R&D Systems) and CD34 (BD Biosciences, 340430). Cells were analyzed using a BD FACSCANTO II or sorted on a BD FACSARIA II (Beckton Dickinson, San Jose, CA) with FACS Diva software (BD Biosciences). Instrument settings were adjusted to avoid spectral overlap.
Quantitative Reverse Transcriptase PCR (RT-qPCR).
Total RNA isolation was performed as per manufacturers' protocol (RNeasy Miniprep Kit, QIAGEN). First-strand cDNA from 500 ng total RNA was synthesized using the Superscript III enzyme kit (Invitrogen). Quantitative RT-PCR was conducted using the Sensimix SYBR PCR Kit (Bioline) on a 7900HT Fast-Real-Time PCR system (Applied Biosystems). Relative transcript values were normalized to either HPRT (human) or β-actin (zebrafish) and primers are listed in Table S1 . Figure 1C is based on the following data set: NCBI Gene Expression Omnibus (GEO; GSE35583, epigenetics; GSE19090, gene expression; previously deposited (Paige et al., 2012) . Figure 1F is based on the following data set: GEO: GSE97080 (Palpant et al., 2017) .
Analysis of RNA-seq and chromatin dynamics.
In situ hybridization.
Wild type zebrafish embryos were collected at 13 and 22 hpf, fixed in 4% paraformaldehyde, dehydrated to methanol, and stored at -20°C until needed. A 613 base pair fragment spanning of alpk2 was amplified from embryonic zebrafish cDNA using primers listed in Table S1 and the digoxigenin-UTP (Roche) antisense alpk2 riboprobe was synthesized using T7 RNA polymerase (Promega). The gata4 riboprobe was previously synthesized (Paige et al., 2012) and in situ hybridization was performed as previously described . Images were obtained using a Nikon SMZ1500 microscope using a Nikon Digital DS-Ri1 camera.
Morpholino Oligonucleotides.
Translation and splice blocking morpholino oligonucleotides (MO) (GeneTools LLC, Philomath, OR) were injected into one-cell zebrafish embryos (0.25-1 ng/embryo).
Validation of splicing was confirmed by reverse transcriptase PCR following first strand cDNA synthesis (Invitrogen) using primers designed to amplify the flanking region of intron-exon 4 (f1, r1; exons 4-6) as well as downstream the splice junction (f2, r2; exons 5-6). Primers and MO sequences can be found in Table S1 and validation is illustrated in Figure 2A -D.
CRISPR/Cas9 gene editing
Human and zebrafish guide sequences were designed using CRISPRscan software (Moreno-Mateos et al., 2015) and are listed in Table S1 . Human sgRNA oligonucleotides were designed with overhangs for ligation into a BbsI (ThermoFisher
Addgene plasmid # 62988) single vector expression system (Ran et al., 2013) . Human PSCs were transfected with 1 μg of the ALPK2 sgRNA-PX459 plasmid using GeneJuice (EMD Millipore and hESCs with plasmid integration were selected using puromycin (InvivoGen). Confirmation of mutation and stop codon was conducted by Sanger sequencing. Zebrafish sgRNA and nCas9 was synthesized, injected, and screed as previously described (Hofsteen et al., 2016) . Founder fish (F0) were outcrossed to with wild type AB fish to generate a stable Alpk2 hemizygous line (F1). F1 fish were subsequently propagated and hemizygous fish were bred to attain homozygosity.
Validation of mutations were conducted through Sanger sequencing. Guide sequences and primers used for validation are listed in Table S1 .
Immunohistochemistry and confocal microscopy.
Zebrafish antibody staining was performed as previously described . Primary antibody used was rabbit anti-DsRed (AnaSpec, Fremont, CA) at 1:200 in phosphate buffered saline with 0.03% triton and 4% bovine serum albumin (PBT) followed by secondary antibody Alexafluor 568 at 1:100 in PBT. Samples were mounted with Vectashield containing DAPI (Vector Laboratories) and images were obtained using a Nikon A1R confocal mounted on a Nikon TiE inverted microscope.
Zebrafish heart rate, cardiomyocyte quantification, and O-dianisidine staining.
Heart rate was collected by counting ventricular contractions from randomly selected fish over a period of one minute at 27˚C (Video S1). Zebrafish (cmlc2:DsRed-nuc) were injected with control or Alpk2 MO, fixed at 48 hpf and processed for IHC as described above. Fish were stained for rabbit anti-DsRed (1:200, AnaSpec, Fremont, CA) and mouse anti-activated leukocyte cell adhesion molecule (ALCAM, 1:50) primary antibodies followed by secondary staining with Alexaflour-596 anti-rabbit and -633 antimouse at 1:100. Hearts were imaged (z-series) by confocal microscopy and cardiomyocytes were counted in a blinded fashion. O-dianisidine staining was performed by staining control and Alpk2Δ5 zebrafish at 72 hpf with a o-dianisidine solution (o-dianisidine (0.6 mg/ml), 0.01 M sodium acetate (pH 4.5), 0.65% H202, and 40% (vol/vol) ethanol)) as previously described (Paffett-Lugassy and Zon, 2005) . Briefly, fish were dechorionated and stained in the dark for 25 minutes at room temperature, washed 3x with deionized H20 and fixed overnight with 4% paraformaldehyde in PBS (vol/vol) at 4˚C. Embryos were bleached as described (Paffett-Lugassy and Zon, 2005) and imaged using a Nikon SMZ1500 microscope using a Nikon Digital DS-Ri1 camera.
Short hairpin RNA (shRNA) and lentiviral transduction.
Three non-overlapping shRNAs targeting various regions of the ALPK2 transcript were inserted into a PLKO.1 vector containing a puromyocin resistance cassette (TRCN0000230560, NM_05947.3-368s21c1; TRCN0000230561, NM_05947.3-1217s21c1; TCRN0000230562, NM_052947.3-5858s21c1; Sigma, Table S1 ). Lentivirus was synthesized and cells were transfected in suspension containing 10 µM Y-27632 (Sigma). For control, cells were transduced with a lentivirus containing a non-targeting shRNA (Sigma). Cells were transduced for 48 hours, puromyocin selected and passaged for expansion once prior to cardiac differentiation. To validate the efficiency of ALPK2 knockdown, we transduced cardiomyocytes with three non-overlapping ALPK2
shRNAs. All ALPK2 shRNAs resulted in significant reduction (72-83%) of ALPK2 when compared to the empty vector shRNA controls ( Figure 4B ). For assessing WNT/β-catenin activity, hESCs were transduced with a lentiviral β-catenin-activated reporter (BAR) driving venus as previously reported (Palpant et al., 2015b) .
Western Blotting
Cells were lysed in ice-cold cell lysis buffer (Cell Signaling, cat# 9803) containing protease inhibitors (Calbiochem, cat# 539134) and quantification of total protein was conducted using the Pierce BCA Protein Assay Kit (Thermo Scientific). Normalized total protein was subjected to SDS-PAGE and western blotting was performed as previously described (Yang et al., 2014) . Primary antibodies used are listed below were coupled with either anti-mouse, anti-goat or anti rabbit horseradish peroxidase secondary antibody at 1:5000 (Santa Cruz Biotechnology). 
Proteomics
Label Free Quantitative Proteomics was conducted as previously published (Hofsteen et al., 2016) and described in detail in the supplemental experimental procedures. In brief, hESCs, CPCs and cardiomyocytes treated with either control or ALPK2 shRNA (2 biological replicates per time point/treatment) were pooled and washed in 1xPBS and flash frozen. Cell pellets were lysed in 1M urea, 50mM ammonium bicarbonate, pH 7.8, and heated to 50°C for 20min. Cell debris was removed by centrifugation (1000g, 2min). Identification and label free quantification of peptides was done with MaxQuant 1.5 using a 1% false discovery rate (FDR) against the human Swiss-Prot/TrEMB database reverse human sequences as well as common contaminants. We analyzed two biological replicates per condition with six technical replicates. Peptides were searched using a 5ppm mass error and a match between run window of 2min. Gene ontology term analysis was conducted using DAVID functional analysis. 
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